GnRH agonist could be responsible for cardiovascular toxicity not only through indirect mechanism, in which hypogonadism plays a critical role in the onset of metabolic syndrome, but also through the direct mechanism due to possible presence of GnRH receptors on the heart leading to lower cardiac contractility [47]. The gene discussed is GNRH1; the disease is hypogonadism.